A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury
Start date
01 February 2018End date
31 July 2019Team
Principal investigator
Research themes
Find out more about our research at Surrey:
Cookies
We use cookies to help our site work, to understand how it is used, and to tailor ads that are more relevant to you and your interests.
By accepting, you agree to cookies being stored on your device. You can view details and manage settings at any time on our cookies policy page.
